Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1931
interventional 1489
Observational 421
Registry 21

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 385
Drug|placebo 309
Device 200
Other 192
Behavioral 161
Procedure 51
Device|Other 21
Biological 12
Device|Drug 12
Dietary Supplement 12
Behavioral|Other 10
Behavioral|Device 9
Dietary Supplement|placebo 9
Drug|Other 9
Device|placebo 8
Diagnostic Test 8
Drug|Procedure 8
Biological|Other 5
Other|Procedure 5
Device|Procedure 4
Genetic 4
Other|placebo 4
Biological|placebo 3
Drug|Other|placebo 3
Radiation 3
Behavioral|Drug 2
Behavioral|Drug|placebo|Procedure 2
Behavioral|Procedure 2
Biological|Procedure 2
Device|Diagnostic Test 2
Device|Drug|placebo 2
Drug|Radiation 2
placebo 2
Behavioral|Biological|Diagnostic Test|Other 1
Behavioral|Device|Drug 1
Behavioral|Dietary Supplement|placebo 1
Behavioral|Other|Procedure 1
Behavioral|Other|Radiation 1
Behavioral|placebo 1
Behavioral|Radiation 1
Biological|Drug 1
Combination Product 1
Combination Product|Drug|placebo 1
Combination Product|placebo 1
Device|Diagnostic Test|Other 1
Device|Drug|Other 1
Device|Drug|Other|placebo 1
Device|Drug|Other|Radiation 1
Device|Genetic 1
Diagnostic Test|Drug 1
Diagnostic Test|Other 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|placebo 1
Dietary Supplement|Other 1
Drug|Genetic|Other 1
Drug|Other|Radiation 1
Drug|Procedure|Radiation 1
Genetic|Other 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 555
NA 113
France 108
Italy 46
Canada 42
China 38
Germany 38
Brazil 34
United Kingdom 34
Japan 33
Taiwan 26
Spain 25
Korea, Republic of 24
Portugal 18
Sweden 18
Belgium 17
Israel 17
Netherlands 16
Turkey 15
Switzerland 14
United States|Canada 13
Denmark 11
Austria 8
Australia 5
Finland 5
Norway 5
Finland|Sweden 4
Malaysia 4
Cuba 3
Egypt 3
France|United Kingdom 3
Hong Kong 3
Hungary 3
Mexico 3
Slovenia 3
Thailand 3
United States|Puerto Rico 3
Argentina 2
Austria|Czech Republic|Hungary|India|Italy|Korea, Republic of|Philippines|Poland|Russian Federation|Slovakia|Spain|Sweden|Ukraine|United Kingdom 2
Austria|France|Germany|Italy|Spain|United Kingdom 2
Belgium|Germany 2
Ireland 2
New Zealand 2
Poland 2
Singapore 2
South Africa 2
United States|Austria|Canada|France|Germany|Hungary|Italy|Slovakia|Spain|Switzerland 2
United States|Austria|France|Germany|Spain 2
United States|Belgium 2
United States|Canada|Czechia|Poland|Spain 2
United States|Canada|Puerto Rico 2
United States|Germany 2
United States|Israel 2
United States|Netherlands 2
Australia|Austria|Belgium|Croatia|Czech Republic|Finland|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Norway|Poland|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Australia|Canada|Finland|France|Germany|Italy|Japan|Spain 1
Australia|Germany|Sweden|United Kingdom 1
Australia|Korea, Republic of|Malaysia|Singapore|Taiwan 1
Australia|New Zealand 1
Australia|Philippines|Taiwan|Thailand 1
Australia|Spain 1
Austria|Belgium|Bulgaria|Czech Republic|France|Germany|Hungary|Italy|Romania|Slovakia|Spain|Switzerland 1
Austria|Canada|Denmark|France|Germany|Morocco|Netherlands|Portugal|South Africa|Spain|Sweden|Tunisia|United Kingdom 1
Austria|Canada|France|Germany|South Africa 1
Austria|Czechia|France|Germany|Netherlands|Portugal|Spain|United Kingdom 1
Austria|Denmark|France|Germany|Netherlands|Spain|United Kingdom 1
Austria|Finland|France|Germany|Italy|Netherlands|Norway|Romania|Russian Federation|South Africa|Spain|Sweden|Ukraine 1
Austria|France|Germany|Italy|Spain 1
Austria|France|Germany|Netherlands|Spain|United Kingdom 1
Austria|Germany|Italy|Spain 1
Austria|Germany|United Kingdom 1
Belarus 1
Belgium|Israel 1
Belgium|Israel|Italy|Netherlands|United Kingdom 1
Belgium|Netherlands|United Kingdom 1
Bolivia 1
Brazil|Canada 1
Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Romania|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
Bulgaria|Malta|Serbia 1
Canada|Finland|France|Netherlands|Spain|Switzerland|United Kingdom 1
Canada|France|Germany|United Kingdom 1
Chile 1
China|Japan 1
Czech Republic|France|Germany|Italy|Serbia|Spain 1
Czech Republic|Germany|Hungary|Poland|Romania|Spain|United Kingdom 1
Czechia 1
Denmark|Finland|Germany|Ireland|Sweden|United Kingdom 1
Finland|Czech Republic|Australia|Austria|Croatia|France|Germany|Hungary|Israel|Italy|New Zealand|Norway|Poland|South Africa|Spain|Sweden|United Kingdom 1
Finland|Germany|Hungary|Latvia 1
France|Germany 1
France|Germany|Netherlands 1
France|Netherlands 1
France|Russian Federation 1
Germany|Hungary|Portugal|Romania|South Africa|France|United States|Belgium|Bulgaria|Canada|United Kingdom 1
Germany|Ireland 1
Germany|Poland 1
Germany|South Africa 1
Germany|Sweden|United Kingdom 1
Greece 1
Hungary|Austria|Belgium|Czech Republic|Estonia|France|Germany|Israel|Italy|Lithuania|Poland|Portugal|Serbia|South Africa|Spain|Sweden|United Kingdom 1
Hungary|United States|Belgium|Czech Republic|France|Germany|Italy|Poland|Spain 1
Iceland 1
India 1
India|Israel|United Kingdom 1
Israel|Poland|Serbia 1
Israel|Serbia|United Kingdom 1
Italy|Austria|France|Germany|Spain|United Kingdom 1
Japan|Korea, Republic of|Taiwan 1
Jordan 1
Mexico|United States|Argentina|Belgium|Bulgaria|Canada|Chile|Colombia|Croatia|Finland|India|Israel|New Zealand|Peru|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine 1
Norway|Sweden|United Kingdom 1
Poland|Portugal|United States|Australia|Czech Republic|Estonia|France|Germany|India|Italy|Lithuania|Malaysia|Netherlands|South Africa|Spain|Taiwan|Thailand|United Kingdom 1
Poland|Portugal|United States|Australia|Czech Republic|Estonia|Germany|India|Italy|Lithuania|Malaysia|Netherlands|South Africa|Taiwan|Thailand 1
Poland|United States|Canada|Czech Republic|Germany|Israel|Italy|Serbia 1
Portugal|Romania|Ukraine 1
Romania|Ukraine 1
Russian Federation 1
Serbia|United Kingdom 1
Slovakia 1
Slovakia|Taiwan 1
Sweden|United Kingdom 1
United States|Albania|Argentina|Brazil|Bulgaria|Canada|Chile|Colombia|Latvia|Lithuania|Peru|Russian Federation|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Colombia|France|Germany|Greece|Italy|Mexico|Peru|Puerto Rico|Spain 1
United States|Argentina|Austria|Czech Republic|Finland|Germany|Hungary|India|Japan|Malaysia|Russian Federation|Slovakia|Taiwan|Ukraine 1
United States|Argentina|Belgium|Bulgaria|Canada|Chile|Colombia|Croatia|Finland|India|Israel|Mexico|New Zealand|Peru|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czech Republic|Finland|Germany|India|Italy|Mexico|Peru|Poland|Portugal|Slovakia|South Africa|Spain 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Colombia|Latvia|Lithuania|Peru|Russian Federation|Ukraine 1
United States|Argentina|Canada|Chile|Romania|Ukraine 1
United States|Argentina|Chile|Estonia|Korea, Republic of|Russian Federation|Slovakia 1
United States|Argentina|Mexico|Puerto Rico 1
United States|Australia 1
United States|Australia|Austria|Belgium|Canada|Estonia|France|Germany|Hungary|India|Israel|Korea, Republic of|Malaysia|Netherlands|New Zealand|Slovakia|Spain|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Finland|Germany|Hungary|Italy|New Zealand|Poland|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|France|Germany|Greece|Israel|Italy|Norway|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Germany|Italy|Japan|Netherlands|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Italy|Japan|Netherlands|Spain|United Kingdom 1
United States|Australia|Canada|Czech Republic|Finland|Germany|Israel|Italy|Netherlands|New Zealand|Poland|Portugal|Russian Federation|Spain|Thailand|United Kingdom 1
United States|Australia|Canada|Czechia|Israel|New Zealand|Poland|Portugal|Russian Federation|Thailand|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy 1
United States|Australia|Canada|Germany|Greece|Italy|Korea, Republic of|Spain|Sweden 1
United States|Australia|France 1
United States|Austria|Belgium|Canada|Finland|France|Germany|Greece|Italy|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Austria|Belgium|Canada|France|India|Italy|Poland|Portugal|Russian Federation|Serbia|Sweden|Ukraine|United Kingdom 1
United States|Austria|Belgium|Czechia|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Serbia|Spain|United Kingdom 1
United States|Austria|Belgium|Italy|Poland|Portugal|Serbia|Spain|Sweden 1
United States|Austria|Canada|Czechia|France|Germany|Italy 1
United States|Austria|Canada|France 1
United States|Austria|Canada|France|Germany|Greece|Israel|Italy|Japan|Norway|Portugal|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
United States|Austria|Canada|France|Germany|Israel|Italy|Spain|United Kingdom 1
United States|Austria|Canada|France|Germany|Italy|Spain|United Kingdom 1
United States|Austria|Czech Republic|Finland|France|Germany|Hungary|India|Japan|Malaysia|Netherlands|Russian Federation|Slovakia|Taiwan|Ukraine 1
United States|Austria|Czechia|France|Germany|Israel|Italy|Poland|Spain 1
United States|Austria|Czechia|Hungary|Israel|Poland|Russian Federation|Spain 1
United States|Austria|Finland|France|Germany|Italy|Japan|Spain|Sweden|United Kingdom 1
United States|Austria|France|Germany 1
United States|Austria|France|Germany|Spain|United Kingdom 1
United States|Austria|Germany|Israel|Italy|South Africa|Spain|United Kingdom 1
United States|Austria|Hungary|Poland|Slovakia|Slovenia|Spain 1
United States|Austria|Israel|Italy 1
United States|Belgium|Czech Republic|France|Hungary|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|France 1
United States|Belgium|Germany|Italy|Poland|Spain 1
United States|Brazil|Canada|France|Germany|Italy|Netherlands|Portugal|United Kingdom 1
United States|Bulgaria|France|India|Russian Federation|Ukraine|United Kingdom 1
United States|Canada|Czech Republic|France|Germany|Hungary|Poland|Romania|Serbia|United Kingdom 1
United States|Canada|Czechia|Germany|Israel|Italy|Poland|Serbia 1
United States|Canada|Czechia|Israel|Italy|Poland|Portugal|Turkey 1
United States|Canada|Estonia|Germany|Latvia|Lithuania|Poland|Romania|Spain|Ukraine 1
United States|Canada|Estonia|Latvia|Lithuania|Romania|Ukraine 1
United States|Canada|France|Germany|Hungary|Italy|Spain 1
United States|Canada|France|Germany|Poland|Romania|Spain|Ukraine 1
United States|Canada|Germany|Spain 1
United States|Canada|Israel|Italy|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Canada|Israel|Norway|Spain|United Kingdom 1
United States|Chile|India|Mexico|Peru 1
United States|Czechia|France|Germany|Hungary 1
United States|Czechia|France|Germany|Italy|Spain 1
United States|Czechia|France|Germany|Italy|Spain|United Kingdom 1
United States|Estonia|Germany|Hungary|Poland|Slovakia 1
United States|Estonia|Korea, Republic of|Russian Federation|Slovakia 1
United States|Finland|Greece|Hungary|Italy|Slovakia|Spain 1
United States|France|Germany|Italy 1
United States|Germany|New Zealand 1
United States|Germany|Poland|Slovakia 1
United States|Germany|United Kingdom 1
United States|Guatemala|Romania 1
United States|Hungary|Poland|Slovakia|Spain 1
United States|India 1
United States|India|Italy 1
United States|Italy 1
United States|Italy|Serbia|United Kingdom 1
United States|Korea, Republic of|Malaysia|Singapore|Taiwan 1
United States|New Zealand 1
United States|Spain 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 1040
2 94
3 37
4 22
5 19
6 13
7 18
8 13
9 7
10 7
11 12
12 11
13 8
14 3
15 10
16 5
17 4
18 10
19 2
20 12
21 7
22 6
23 2
24 7
25 4
26 2
27 2
28 2
29 4
31 4
32 4
33 4
34 3
36 2
38 2
39 3
40 1
41 1
42 4
45 2
46 2
47 3
50 3
51 2
52 2
53 2
54 2
55 3
56 1
57 2
58 1
60 3
61 2
62 1
63 2
64 1
65 1
70 2
73 3
74 2
75 4
76 4
77 3
78 2
81 2
83 1
87 3
89 2
95 1
99 1
102 1
105 1
111 1
114 1
118 1
119 1
121 1
125 1
127 1
128 1
130 1
135 2

Phase

Phase Study_Count
N/A 641
Phase 2 274
Phase 1 189
Phase 3 184
Phase 4 97
Phase 1/Phase 2 56
Phase 2/Phase 3 30
Early Phase 1 18

Number of Arms

Number_of_Arms Count_of_Studies
1 324
2 719
3 184
4 94
5 27
6 9
7 3
8 5
9 2
11 1
14 2
NA 119

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00 2.0000 3.00000 4.00000 2.0000 11.0000 1.0000 5.0000
1st Qu. 16.25 20.0000 16.00000 15.00000 26.7500 36.0000 100.0000 28.0000
Median 20.50 38.0000 25.00000 22.00000 49.5000 70.0000 254.0000 55.0000
Mean 25.50 163.3703 33.45699 38.46429 468.4301 106.5517 282.0734 143.2784
3rd Qu. 30.00 72.2500 45.75000 40.00000 105.2500 149.0000 400.0000 127.0000
Max. 75.00 53480.0000 158.00000 301.00000 100000.0000 420.0000 1174.0000 3500.0000

Trial Group Type

group_type Group_Count
Experimental 1652
Active Comparator 561
Placebo Comparator 405
Other 175
NA 119
No Intervention 114
Sham Comparator 90

Intervention Model

intervention_model Study_Count
Parallel Assignment 820
Single Group Assignment 394
Crossover Assignment 205
NA 30
Sequential Assignment 23
Factorial Assignment 17

Primary Purpose

primary_purpose Study_Count
Treatment 1113
Basic Science 83
Other 75
Diagnostic 69
Supportive Care 64
NA 28
Prevention 22
Health Services Research 17
Screening 9
Device Feasibility 8
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 191
NA 41
France 27
China 23
Germany 15
Italy 14
United Kingdom 11
Canada 10
Japan 8
Denmark 7
Turkey 7
Taiwan 6
Netherlands 5
Spain 4
United States|Canada 4
Finland 3
Switzerland 3
Austria 2
Egypt 2
Israel 2
Korea, Republic of 2
Austria|Canada|Croatia|Czechia|Greece|Hungary|Ireland|Israel|Romania|Spain|Sweden 1
Austria|Estonia|Kazakhstan|Romania|Serbia|Slovakia|Slovenia 1
Austria|France|Germany|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Germany 1
Belgium|France|Germany|Italy 1
Belgium|France|Italy|Switzerland|Turkey 1
Brazil 1
Brazil|China 1
Croatia|Czech Republic|Estonia|Hungary|Romania|Russian Federation|Serbia|Slovakia|Slovenia 1
Croatia|France|Germany|Slovenia 1
Estonia|Latvia|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Ukraine 1
France|Germany 1
France|Germany|Italy|Spain|United Kingdom 1
France|Germany|Turkey 1
France|Guadeloupe 1
Germany|Italy|Spain 1
Germany|Switzerland 1
Germany|Thailand 1
Hong Kong 1
Israel|Italy 1
Malaysia 1
Russian Federation 1
Spain|Czechia|Denmark|Germany|Greece|Italy|Mexico|Romania|Slovakia|Switzerland 1
Spain|United States|Argentina|Canada|France|Germany|Hungary|Israel|Italy|Netherlands|Portugal|Romania|United Kingdom 1
Sweden 1
Thailand 1
United States|Albania|Belgium|Brazil|Germany|Greece|Israel|Italy|Spain|Turkey|United Kingdom 1
United States|Argentina|Korea, Republic of|Spain 1
United States|Australia|Belgium|Hungary|Israel|Italy|Romania|Slovenia|Spain|United Kingdom 1
United States|Canada|Israel|Netherlands 1
United States|Canada|Puerto Rico 1
United States|Germany 1
United States|Germany|Italy 1
United States|Germany|Taiwan 1

Sites per Study

Site_count Study_Count
1 328
2 19
3 11
4 4
5 6
6 4
7 3
8 1
9 2
10 1
12 3
13 2
14 1
15 3
20 1
21 1
24 2
27 2
30 2
32 1
42 1
49 1
52 1
54 2
57 2
58 1
59 1
76 1
98 1
102 1
103 1
118 1
119 1
140 1
211 1
215 1
238 1
273 1
278 1
284 1
311 1
317 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 38.000
Median 100.000
Mean 1894.823
3rd Qu 383.250
Max 214962.000

Observation Model

observational_model Study_Count
Cohort 183
Case-Control 71
NA 53
Case-Only 48
Case Control 31
Other 21
Ecologic or Community 6
Case-Crossover 2
Defined Population 2
Family-Based 2
Defined Population, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 261
Cross-Sectional 89
NA 29
Retrospective 28
Other 10
Longitudinal, Retrospective/Prospective 2
Cross-Sectional, Prospective 1
Cross-Sectional, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
NA 3
Turkey 3
United States 3
Italy 2
Egypt 1
Israel 1
Korea, Republic of 1
Mexico 1
Netherlands 1
Sweden 1
Taiwan 1
United Kingdom 1
United States|Canada 1
United States|Canada|Israel 1

Sites per Study

Site_count Study_Count
1 16
2 2
7 2
8 1

Enrollment Metrics

Measure Registries
Min 18.0
1st Qu 60.0
Median 300.0
Mean 283249.9
3rd Qu 550.0
Max 5940299.0

Registry Model

observational_model Study_Count
Cohort 11
Case-Control 4
Case-Only 2
Case Control 1
Ecologic or Community 1
Family-Based 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 15
Cross-Sectional 4
Other 1
NA 1

Follow-up

target_duration Study_Count
1 Day 3
2 Years 3
3 Years 3
5 Years 3
1 Week 2
1 Month 1
13 Weeks 1
15 Years 1
17 Years 1
6 Months 1
7 Days 1
8 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04428931 Attentional Performance in Parkinson Disease https://ClinicalTrials.gov/show/NCT04428931 Recruiting National Institutes of Health Clinical Center (CC) 2030-03-04
NCT03845634 Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03845634 Completed Assistive Technology Clinic, Canada 2019-09-11
NCT03383497 The Clinical Profile of Parkinson Disease in Egypt https://ClinicalTrials.gov/show/NCT03383497 Completed Cairo University 2016-12-31
NCT03371407 Movement Error-processes and Sensorimotor Adaptation in Parkinsonian Patient https://ClinicalTrials.gov/show/NCT03371407 Recruiting Assistance Publique Hopitaux De Marseille 2020-12-31
NCT03364894 The Personalized Parkinson Project (PPP) https://ClinicalTrials.gov/show/NCT03364894 Recruiting Radboud University 2021-10-31
NCT03363724 Validation of HaGuide Software Module Accuracy in Mapping STN Boundaries in Parkinson’s Disease Patients Who Underwent DBS Procedure https://ClinicalTrials.gov/show/NCT03363724 Completed Alpha Omega Engineering Ltd. 2017-03-30
NCT03362879 COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel https://ClinicalTrials.gov/show/NCT03362879 Completed AbbVie 2018-12-17
NCT03336697 Determining the Microbiota Composition of the Middle Meatus in Parkinson’s https://ClinicalTrials.gov/show/NCT03336697 Completed Rush University Medical Center 2019-03-10
NCT03336307 Predictors of Gait Improvement in Patients With Parkinson’s Disease After Rehabilitation https://ClinicalTrials.gov/show/NCT03336307 Completed University of Roma La Sapienza 2017-04-30
NCT03321019 Airway Protective Mechanisms in PD (R01) https://ClinicalTrials.gov/show/NCT03321019 Recruiting University of Florida 2021-11-30
NCT03300193 The Effect of Lesion Characteristics in MRgFUS on Tremor in Essential Tremor and Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03300193 Completed Rambam Health Care Campus 2017-05-31
NCT03288909 Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03288909 Recruiting Oregon Health and Science University 2020-01-31
NCT03285230 The French E3N Prospective Cohort Study https://ClinicalTrials.gov/show/NCT03285230 Active, not recruiting Institut National de la Santé Et de la Recherche Médicale, France 1991-11-15
NCT03279445 Parkinson’s Disease in African American and Caucasian Patients https://ClinicalTrials.gov/show/NCT03279445 Recruiting University of Chicago 2020-06-30
NCT03275649 Help-seeking for Health Problems in People With Parkinson’s https://ClinicalTrials.gov/show/NCT03275649 Completed City, University of London 2018-01-01
NCT03247387 eOnOff - D1 Extension https://ClinicalTrials.gov/show/NCT03247387 Completed Boston University 2018-07-01
NCT03234478 Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers https://ClinicalTrials.gov/show/NCT03234478 Recruiting Rush University Medical Center 2020-06-30
NCT03230331 Follow Up Study for Treatment of Parkinson’s Disease With Subthalamic Deep Brain Stimulation https://ClinicalTrials.gov/show/NCT03230331 Completed Ruijin Hospital 2019-05-01
NCT03227250 Effects of Bilateral GPI DBS on Freezing of Gait in PD https://ClinicalTrials.gov/show/NCT03227250 Recruiting Ruijin Hospital 2020-07-31
NCT03217396 Biomarkers of Synaptic Damage in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT03217396 Recruiting Neuromed IRCCS 2020-09-01
NCT03170063 FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) https://ClinicalTrials.gov/show/NCT03170063 Completed Michael J. Fox Foundation for Parkinson’s Research 2018-03-12
NCT03156647 Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome https://ClinicalTrials.gov/show/NCT03156647 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-07-31
NCT03152292 The INSYTE (Management of Parkinson’s Disease Psychosis in Actual Practice) Study https://ClinicalTrials.gov/show/NCT03152292 Recruiting ACADIA Pharmaceuticals Inc. 2021-09-30
NCT03143374 PET Tau - Neurodegenerative Disease Imaging https://ClinicalTrials.gov/show/NCT03143374 Active, not recruiting University of Pennsylvania 2022-09-30
NCT03137238 Self-motion Perception in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03137238 Recruiting Sheba Medical Center 2019-01-01
NCT03103347 Quantification of Beta Activity in Routine EEG Recordings in Parkinson’s Disease Patients https://ClinicalTrials.gov/show/NCT03103347 Completed Duke University 2017-02-01
NCT03079037 Circuit-Based Deep Brain Stimulation for Parkinson’s Disease; Udall Project 1 Aim 2 and 3 https://ClinicalTrials.gov/show/NCT03079037 Recruiting University of Minnesota 2022-03-31
NCT03073044 Translation and Validation of BELA-p-K for QoL Evaluation in PD Patients https://ClinicalTrials.gov/show/NCT03073044 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2016-09-01
NCT03037463 Measuring Parkinson’s Disease With Tear Fluid https://ClinicalTrials.gov/show/NCT03037463 Active, not recruiting University of Southern California 2023-01-31
NCT03019757 Distinguishing Between Alzheimer’s Disease, Lewy Body Dementia, and Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03019757 Recruiting Ohio State University 2020-12-31
NCT02994719 Gait Analysis in Neurological Disease https://ClinicalTrials.gov/show/NCT02994719 Active, not recruiting Beth Israel Deaconess Medical Center 2021-06-20
NCT02963259 IPG Replacement Study (PREFERENCE-H) https://ClinicalTrials.gov/show/NCT02963259 Active, not recruiting Abbott Medical Devices 2019-12-31
NCT02964611 Social Cognition and Personality Changes in Alzheimer’s & Parkinson’s Disease & Frontotemporal Lobar Degeneration https://ClinicalTrials.gov/show/NCT02964611 Recruiting University Health Network, Toronto 2019-12-31
NCT02939534 Antigen Presentation and Lymphocyte Response in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02939534 Recruiting Columbia University 2020-07-31
NCT02937688 Deep Brain Stimulation (DBS) for Parkinson’s Disease International Study https://ClinicalTrials.gov/show/NCT02937688 Recruiting MedtronicNeuro 2021-04-30
NCT02915848 Long-term Stability of LFP Recorded From the STN and the Effects of DBS https://ClinicalTrials.gov/show/NCT02915848 Active, not recruiting University Health Network, Toronto 2020-07-31
NCT02906488 Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02906488 Active, not recruiting AbbVie 2022-01-31
NCT02894320 Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON’s Disease https://ClinicalTrials.gov/show/NCT02894320 Completed Fondation Ophtalmologique Adolphe de Rothschild 2016-06-30
NCT02881099 Parkinson’s Repository of Biosamples and Network Datasets (Tracking Parkinson’s) https://ClinicalTrials.gov/show/NCT02881099 Active, not recruiting South Glasgow University Hospitals NHS Trust 2021-12-23
NCT02860338 COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE https://ClinicalTrials.gov/show/NCT02860338 Completed Clionsky Neuro Systems Inc. 2015-12-31
NCT02859805 Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson’s Patient https://ClinicalTrials.gov/show/NCT02859805 Completed Assistance Publique Hopitaux De Marseille 2013-01-31
NCT02837172 Diagnosis of PD and PD Progression Using DWI https://ClinicalTrials.gov/show/NCT02837172 Completed University of Alabama at Birmingham 2019-04-14
NCT02814201 Study of Motor Slowing in Parkinson’s Disease by a Computerized Mental Chronometry Paradigm https://ClinicalTrials.gov/show/NCT02814201 Completed Centre Hospitalier Universitaire, Amiens 2016-11-30
NCT02769039 Predictors of Motor Progression in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02769039 Completed University of Minnesota 2019-05-31
NCT02761707 Biomarkers in Neural Disorders https://ClinicalTrials.gov/show/NCT02761707 Completed University of Pennsylvania 2018-06-30
NCT02763683 Investigations of Dementia in Parkinson Disease https://ClinicalTrials.gov/show/NCT02763683 Recruiting Washington University School of Medicine 2030-03-31
NCT02749214 Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes https://ClinicalTrials.gov/show/NCT02749214 Completed Emory University 2019-05-31
NCT02727270 Measuring Cortisol Levels in Persons With Parkinson’s (PD) https://ClinicalTrials.gov/show/NCT02727270 Recruiting Oregon Health and Science University 2020-12-31
NCT02723396 Sleep, Awake & Move - Part I https://ClinicalTrials.gov/show/NCT02723396 Recruiting Neurocenter of Southern Switzerland 2019-05-31
NCT02712515 The Motor Network in Essential Tremor: Mechanisms of Therapy https://ClinicalTrials.gov/show/NCT02712515 Recruiting University of Florida 2021-03-31
NCT02702232 Shoulder Disorders in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02702232 Completed Shin Kong Wu Ho-Su Memorial Hospital 2017-12-31
NCT02701803 Parkinson’s KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy https://ClinicalTrials.gov/show/NCT02701803 Completed Hospital District of Helsinki and Uusimaa 2017-12-31
NCT02668835 GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson’s Disease Trial https://ClinicalTrials.gov/show/NCT02668835 Completed Scripps Translational Science Institute 2017-02-28
NCT02650843 Non-motor Symptoms and Brain Dopamine Transporter Binding https://ClinicalTrials.gov/show/NCT02650843 Enrolling by invitation Turku University Hospital 2024-12-31
NCT02640339 Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease https://ClinicalTrials.gov/show/NCT02640339 Recruiting NYU Langone Health 2020-02-29
NCT02637089 Longitudinal Study of Mild Cognitive Impairment in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02637089 Recruiting University of Calgary 2020-05-31
NCT02627664 Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02627664 Completed University Hospital, Lille 2017-02-09
NCT02611713 Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02611713 Recruiting AbbVie 2021-03-27
NCT02610634 Visual Function During Gait in Parkinson’s Disease: Impact of Cognition and Response to Visual Cues https://ClinicalTrials.gov/show/NCT02610634 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2015-02-28
NCT02605161 Imaging Blood Brain Imaging Dysfunction in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02605161 Recruiting Ottawa Hospital Research Institute 2020-08-01
NCT02572713 Systemic Synuclein Sampling Study (S4) https://ClinicalTrials.gov/show/NCT02572713 Completed Michael J. Fox Foundation for Parkinson’s Research 2017-08-01
NCT03030586 ADDIA Proof-of-Performance Clinical Study https://ClinicalTrials.gov/show/NCT03030586 Recruiting Amoneta Diagnostics SAS 2021-06-30
NCT01734122 Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor https://ClinicalTrials.gov/show/NCT01734122 Recruiting Vanderbilt University Medical Center 2023-02-28
NCT02569021 Battery-preserving Stimulation Patterns for Deep Brain Stimulation https://ClinicalTrials.gov/show/NCT02569021 Completed University of Florida 2016-04-30
NCT00024622 PET Scanning in Parkinson s Disease https://ClinicalTrials.gov/show/NCT00024622 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01399411 Agricultural Health Study Follow-up https://ClinicalTrials.gov/show/NCT01399411 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02547506 Comparison of Cardiorespiratory Fitness Among Regular Exercisers With and Without Parkinson Disease and Across Different Modes of Group Exercise https://ClinicalTrials.gov/show/NCT02547506 Completed University of Indianapolis 2017-06-30
NCT02522065 neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials https://ClinicalTrials.gov/show/NCT02522065 Completed Fundación de investigación HM 2016-12-31
NCT02524405 BEAM: Brain-Eye Amyloid Memory Study https://ClinicalTrials.gov/show/NCT02524405 Recruiting Sunnybrook Health Sciences Centre 2021-03-31
NCT02523807 Tremor Monitoring Device https://ClinicalTrials.gov/show/NCT02523807 Completed Rambam Health Care Campus 2017-10-30
NCT02511015 Hereditary Parkinson s Disease Natural History Protocol https://ClinicalTrials.gov/show/NCT02511015 Completed National Institutes of Health Clinical Center (CC) 2016-04-07
NCT02509325 Parkinson’s KinetiGraph as Tool for DBS Eligibility Assessment https://ClinicalTrials.gov/show/NCT02509325 Completed Medtronic Bakken Research Center 2016-02-29
NCT02500108 Domperidone and Risk of Sudden Cardiac Death https://ClinicalTrials.gov/show/NCT02500108 Completed Canadian Network for Observational Drug Effect Studies, CNODES 2015-06-30
NCT02485600 Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients https://ClinicalTrials.gov/show/NCT02485600 Completed AbbVie 2020-02-26
NCT02458430 Cholinergic Mechanisms of Gait Dysfunction in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02458430 Recruiting University of Michigan 2020-12-31
NCT02455219 DatScan With Prototype Collimator https://ClinicalTrials.gov/show/NCT02455219 Completed University of Minnesota 2017-09-30
NCT02453763 In Vivo Imaging of Therapeutic Electric Current Flow https://ClinicalTrials.gov/show/NCT02453763 Completed University of Florida 2017-07-06
NCT02443779 Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02443779 Completed Thomas Jefferson University 2018-07-31
NCT02409823 Clinical Registry of Patients Under Treatment With Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT02409823 Completed Pontifical Catholic University of Argentina 2015-08-31
NCT02403765 Diagnostic Tools for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02403765 Completed Neuromed IRCCS 2018-10-31
NCT02387281 Freezing of Gait: Clinical, Cognitive, and Imaging Features https://ClinicalTrials.gov/show/NCT02387281 Completed Emory University 2017-11-13
NCT02384512 Azilect® In Wearing-Off (AIWO) https://ClinicalTrials.gov/show/NCT02384512 Completed Teva Pharmaceutical Industries 2014-12-31
NCT02381444 Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy https://ClinicalTrials.gov/show/NCT02381444 Completed AbbVie 2020-01-07
NCT02358876 BradyXplore Phase II: Bradykinesia Feature Extraction System https://ClinicalTrials.gov/show/NCT02358876 Completed Great Lakes NeuroTechnologies Inc. 2015-07-31
NCT02360683 Predictive Factors and Subthalamic Stimulation in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02360683 Active, not recruiting University Hospital, Lille 2019-11-30
NCT02320266 Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery https://ClinicalTrials.gov/show/NCT02320266 Recruiting University of Colorado, Denver 2020-12-31
NCT02319694 Intraoperative Analysis of Reward and Impulsivity in the Basal Ganglia https://ClinicalTrials.gov/show/NCT02319694 Completed Duke University 2017-02-27
NCT02319395 Behavioural Addiction and Genetics in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02319395 Completed Assistance Publique - Hôpitaux de Paris 2015-11-30
NCT02302521 Motion Immune Magnetic Resonance Imaging (MRI) https://ClinicalTrials.gov/show/NCT02302521 Completed Duke University 2016-11-26
NCT02305147 Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02305147 Recruiting Institut National de la Santé Et de la Recherche Médicale, France 2019-11-06
NCT02289729 Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02289729 Completed AbbVie 2016-11-30
NCT02283073 Study for the Early Diagnosis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02283073 Active, not recruiting Bio Shai Ltd. 2019-12-31
NCT02278588 Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson’s Disease. https://ClinicalTrials.gov/show/NCT02278588 Completed University at Buffalo 2017-12-31
NCT02251808 Satisfaction Survey on PINS Stimulator System for Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02251808 Recruiting Beijing Pins Medical Co., Ltd 2024-09-30
NCT02248220 Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02248220 Completed Boehringer Ingelheim 1999-10-31
NCT02248207 Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02248207 Completed Boehringer Ingelheim 2003-11-30
NCT02248181 Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02248181 Completed Boehringer Ingelheim 2005-12-31
NCT02248168 Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02248168 Completed Boehringer Ingelheim 2007-01-31
NCT02239978 Effect of Levodopa on Postural Motor Learning in Parkinson Disease https://ClinicalTrials.gov/show/NCT02239978 Completed VA Office of Research and Development 2016-01-31
NCT02236728 Observational Study in Parkinson’s Disease of the Primary Care Population of Patients Treated With Pramipexole https://ClinicalTrials.gov/show/NCT02236728 Completed Boehringer Ingelheim 2008-11-30
NCT02231294 The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02231294 Completed Boehringer Ingelheim 2002-01-31
NCT02231255 Post Marketing Surveillance Study in Patients With Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02231255 Completed Boehringer Ingelheim 2002-12-31
NCT02227355 Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02227355 Completed UCB Pharma 2016-06-30
NCT02216435 Using Parkinson’s Disease to Study the Role of the Substantia Nigra Pars Reticulata https://ClinicalTrials.gov/show/NCT02216435 Recruiting University of Colorado, Denver 2020-07-31
NCT02202057 Respiratory Load Magnitude Estimation in PD https://ClinicalTrials.gov/show/NCT02202057 Completed University of Florida 2016-05-31
NCT02200887 Sleep Homeostasis in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02200887 Completed Ospedale Civico, Lugano 2015-06-30
NCT02184546 Outcomes Data of Adipose Stem Cells to Treat Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02184546 Active, not recruiting StemGenex 2019-07-31
NCT02168504 Electromyography Signals as Biomarkers for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02168504 Completed Norconnect Inc 2015-09-30
NCT03384797 Blood Biomarker in Early Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03384797 Completed Duke University 2019-01-07
NCT02132052 Defining Phenotypes of Movement Disorders :Parkinson’s Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. https://ClinicalTrials.gov/show/NCT02132052 Active, not recruiting University of Colorado, Denver 2020-12-31
NCT02125825 Ambulatory Parkinson’s Disease Dyskinesia Monitor for Drug Therapy Titration https://ClinicalTrials.gov/show/NCT02125825 Completed Great Lakes NeuroTechnologies Inc. 2014-12-31
NCT02114242 Biomarkers in Parkinsonian Syndromes https://ClinicalTrials.gov/show/NCT02114242 Recruiting University Hospital, Bordeaux 2021-12-16
NCT02101528 Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer https://ClinicalTrials.gov/show/NCT02101528 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2013-12-31
NCT02098642 Hallux Mobilization in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02098642 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2013-11-30
NCT02098577 Crossover Versus Stabilometric Platform in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02098577 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2014-02-28
NCT02080572 Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS https://ClinicalTrials.gov/show/NCT02080572 Completed Great Lakes NeuroTechnologies Inc. 2014-12-31
NCT02073981 Observational Study for Non-motor Symptoms and Treatment in Parkinson’s Disease Patients https://ClinicalTrials.gov/show/NCT02073981 Active, not recruiting Kyowa Kirin Co., Ltd. 2016-05-31
NCT02076295 Cholinergic Nicotinic Receptors and Cognition in PD https://ClinicalTrials.gov/show/NCT02076295 Completed University of Michigan 2016-12-30
NCT02071693 A Retrospective Study of the Relationship Between White Matter Hyperintensities(WMHs) Within the Cholinergic Pathways and the Cognition of PD Patients After Bilateral STN DBS https://ClinicalTrials.gov/show/NCT02071693 Completed First Affiliated Hospital, Sun Yat-Sen University 2014-03-31
NCT02071446 Local Fields Potentials Recorded From Deep Brain Stimulating Electrodes https://ClinicalTrials.gov/show/NCT02071446 Completed University of Colorado, Denver 2017-11-29
NCT01316666 Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension https://ClinicalTrials.gov/show/NCT01316666 Completed Vanderbilt University Medical Center 2016-12-31
NCT01272687 Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson’s Disease for Phenotype-genotype Correlation https://ClinicalTrials.gov/show/NCT01272687 Completed Centogene AG Rostock 2016-06-30
NCT01270711 Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE) https://ClinicalTrials.gov/show/NCT01270711 Completed Pfizer 2013-02-28
NCT02034318 Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease https://ClinicalTrials.gov/show/NCT02034318 Completed University of Miami 2015-01-31
NCT03027310 Clinical and Physiological Studies of Tremor Syndromes https://ClinicalTrials.gov/show/NCT03027310 Recruiting National Institutes of Health Clinical Center (CC) 2022-01-01
NCT02012595 [11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease https://ClinicalTrials.gov/show/NCT02012595 Completed University of Aarhus 2015-01-31
NCT01997398 DBS Under General Anesthesia: Comparison To The Standard Technique https://ClinicalTrials.gov/show/NCT01997398 Completed St. Joseph’s Hospital and Medical Center, Phoenix 2014-12-31
NCT01998204 Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01998204 Completed Changhai Hospital 2013-06-30
NCT01996878 Genetic Polymorphism and Parkinson’s Disease in Taiwanese https://ClinicalTrials.gov/show/NCT01996878 Completed Changhua Christian Hospital 2007-02-28
NCT01992692 Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01992692 Completed Changhai Hospital 2013-06-30
NCT01956032 Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources https://ClinicalTrials.gov/show/NCT01956032 Completed AbbVie 2014-11-30
NCT01953718 A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation https://ClinicalTrials.gov/show/NCT01953718 Completed First Affiliated Hospital, Sun Yat-Sen University 2013-10-31
NCT01952678 Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscanâ„¢ Images in Non-Caucasian and Caucasian Subjects With Parkinson’s Disease (PD) or Essential Tremor (ET) https://ClinicalTrials.gov/show/NCT01952678 Completed GE Healthcare 2016-05-31
NCT01935011 DBS Frequency on Swallowing Function in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01935011 Completed University of Chicago 2014-07-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01928212 Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis https://ClinicalTrials.gov/show/NCT01928212 Completed Wenzhou Medical University 2014-01-31
NCT01922388 Early Versus Late Application of STN DBS to PD Patients With Motor Complications https://ClinicalTrials.gov/show/NCT01922388 Recruiting First Affiliated Hospital, Sun Yat-Sen University 2020-12-31
NCT01904240 Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01904240 Completed Rush University Medical Center 2014-06-30
NCT01888185 Identifying Biomarkers of Parkinson’s Disease Using Magnetic Resonance Imaging (MRI) https://ClinicalTrials.gov/show/NCT01888185 Completed Milton S. Hershey Medical Center 2019-12-31
NCT01885494 AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson’s Disease After Immunization With AFFITOPE® PD01A https://ClinicalTrials.gov/show/NCT01885494 Completed Affiris AG 2015-02-28
NCT01877538 Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System https://ClinicalTrials.gov/show/NCT01877538 Completed University of Aarhus 2013-07-31
NCT01862744 Imaging Studies of Cognitive Impairment in Parkinson s Disease https://ClinicalTrials.gov/show/NCT01862744 Completed National Institutes of Health Clinical Center (CC) 2015-01-30
NCT01860118 LRRK2 and Other Novel Exosome Proteins in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01860118 Completed University of Alabama at Birmingham 2016-06-21
NCT01807338 A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01807338 Completed Newron Sweden AB 2014-08-31
NCT01809613 Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01809613 Completed Mayo Clinic 2017-07-27
NCT01799915 Natural History Study of Synucleinopathies https://ClinicalTrials.gov/show/NCT01799915 Recruiting NYU Langone Health 2020-07-31
NCT01798563 Functional Connectivity Parkinson Disease https://ClinicalTrials.gov/show/NCT01798563 Completed University of Colorado, Denver 2017-10-31
NCT01792843 Cognitive Phenotypes in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01792843 Completed University Hospital, Lille 2014-09-30
NCT01792193 Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson’s Disease and Healthy Controls https://ClinicalTrials.gov/show/NCT01792193 Completed Saarland University 2015-12-31
NCT01774383 Investigating the Pathophysiological Roles of Cortical, Sub-thalamic Nuclear and Pedunculo-pontine Nuclear Oscillation in Movement Termination of Parkinson Disease Patients https://ClinicalTrials.gov/show/NCT01774383 Completed China Medical University Hospital 2013-07-31
NCT01767818 Parkinson’s Disease Biomarker Program https://ClinicalTrials.gov/show/NCT01767818 Completed University of Texas Southwestern Medical Center 2017-09-30
NCT01754168 Amyloid Beta and Cognition in Parkinson Disease https://ClinicalTrials.gov/show/NCT01754168 Completed University of Michigan 2018-02-28
NCT01754129 Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa https://ClinicalTrials.gov/show/NCT01754129 Completed AbbVie 2016-05-31
NCT01750242 Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study https://ClinicalTrials.gov/show/NCT01750242 Completed MedtronicNeuro 2013-05-31
NCT01720810 Pacific Northwest Udall Center (PANUC) Clinical Core https://ClinicalTrials.gov/show/NCT01720810 Recruiting University of Washington 2020-06-30
NCT01715727 Diagnosis of Parkinson’s Disease Using Diffusion Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT01715727 Completed Chang Gung Memorial Hospital 2015-09-30
NCT01705418 Behavior Addictions Improvement in Parkinson Disease’s Patients Treated by Subthalamic Stimulation : Long Term Follow-up https://ClinicalTrials.gov/show/NCT01705418 Completed University Hospital, Grenoble 2015-06-30
NCT01705327 Fox Investigation for New Discovery of Biomarkers https://ClinicalTrials.gov/show/NCT01705327 Completed Michael J. Fox Foundation for Parkinson’s Research 2015-03-31
NCT01705301 Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery https://ClinicalTrials.gov/show/NCT01705301 Completed Mayo Clinic 2017-07-27
NCT01662427 Nocturnal Parkinson’s Disease Symptoms Study Group https://ClinicalTrials.gov/show/NCT01662427 Completed Chulalongkorn University 2013-08-31
NCT01648803 Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease https://ClinicalTrials.gov/show/NCT01648803 Completed University of Rochester 2013-06-30
NCT01629043 Parkinson’s Foundation Quality Improvement Initiative https://ClinicalTrials.gov/show/NCT01629043 Recruiting National Parkinson Foundation NA
NCT01606670 Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease https://ClinicalTrials.gov/show/NCT01606670 Completed UCB Pharma 2014-07-31
NCT01592552 A Biospecimen and Clinical Data Study on Patients With Alzheimer’s, Multiple Sclerosis, Parkinson’s, and Huntington’s, for Drug & Biomarker Discovery https://ClinicalTrials.gov/show/NCT01592552 Completed Sanguine Biosciences 2015-03-31
NCT01572142 Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01572142 Completed University of Michigan 2016-07-31
NCT01565473 PET Study of Non-Motor Symptoms of Parkinson Disease https://ClinicalTrials.gov/show/NCT01565473 Completed University of Michigan 2014-07-31
NCT01564992 Drug Interaction With Genes in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01564992 Recruiting Assistance Publique - Hôpitaux de Paris 2019-06-30
NCT01563276 Postural Instability in Progressive Supranuclear Palsy https://ClinicalTrials.gov/show/NCT01563276 Completed Oregon Health and Science University 2013-05-10
NCT01558479 The Parkinson’s Genetic Research Study https://ClinicalTrials.gov/show/NCT01558479 Recruiting University of Washington 2020-06-30
NCT01545856 Cardiovascular Events in Parkinson’s Disease Patients https://ClinicalTrials.gov/show/NCT01545856 Completed GlaxoSmithKline 2011-11-30
NCT01536821 PROGENI (Parkinson’s Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2) https://ClinicalTrials.gov/show/NCT01536821 Completed Indiana University 2013-12-31
NCT01536769 Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01536769 Completed Helsinki University Central Hospital 2015-04-30
NCT01534650 Movement Disorder Quantification Algorithm Development https://ClinicalTrials.gov/show/NCT01534650 Completed Great Lakes NeuroTechnologies Inc. 2016-01-31
NCT01525641 Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01525641 Completed Boehringer Ingelheim 2014-06-30
NCT01519856 PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson’s Disease During Long Term Therapy https://ClinicalTrials.gov/show/NCT01519856 Completed Desitin Arzneimittel GmbH 2014-12-31
NCT01518751 Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson’s Disease - Evolution https://ClinicalTrials.gov/show/NCT01518751 Completed University of Zurich 2013-12-31
NCT01516281 Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury https://ClinicalTrials.gov/show/NCT01516281 Completed NorthShore University HealthSystem 2015-12-31
NCT01504529 Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine https://ClinicalTrials.gov/show/NCT01504529 Completed UCB Pharma 2012-12-31
NCT01496599 Imaging Biomarkers in Parkinson s Disease https://ClinicalTrials.gov/show/NCT01496599 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01465360 Performance of AclarusDxâ„¢, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center https://ClinicalTrials.gov/show/NCT01465360 Completed Exonhit NA
NCT01429220 Automated Parkinson’s Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming https://ClinicalTrials.gov/show/NCT01429220 Completed Great Lakes NeuroTechnologies Inc. 2014-04-30
NCT01427530 Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes https://ClinicalTrials.gov/show/NCT01427530 Completed University of Minnesota 2012-10-31
NCT01429207 Capturing Parkinson’s Disease Medication Side Effects During Daily Activities https://ClinicalTrials.gov/show/NCT01429207 Completed Great Lakes NeuroTechnologies Inc. NA
NCT01381302 Trodat 1 SPECT and Dopamine Polymorphism https://ClinicalTrials.gov/show/NCT01381302 Completed Wolfson Medical Center 2012-08-31
NCT01366027 PRISM Registry: Pseudobulbar Affect Registry Series https://ClinicalTrials.gov/show/NCT01366027 Completed Avanir Pharmaceuticals 2012-09-30
NCT01361009 a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients https://ClinicalTrials.gov/show/NCT01361009 Completed Boehringer Ingelheim 2012-02-29
NCT01356056 Tele-diagnostics for Remote Parkinson’s Monitoring https://ClinicalTrials.gov/show/NCT01356056 Completed Great Lakes NeuroTechnologies Inc. 2011-12-31
NCT01358474 Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism https://ClinicalTrials.gov/show/NCT01358474 Completed University of Minnesota 2014-10-31
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson’s Disease Study https://ClinicalTrials.gov/show/NCT01352819 Completed Abbott Medical Devices 2013-03-31
NCT01351467 Web-based Genetic Research on Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01351467 Active, not recruiting 23andMe, Inc. 2025-01-31
NCT01338662 Comparison of the Incidence of Dyskinesia in Parkinson`s Disease Who Were Treated With Amantadine or Dopamine Agonist https://ClinicalTrials.gov/show/NCT01338662 Recruiting Seoul National University Hospital 2020-04-30
NCT01330290 Caregivers’ and Physicians’ Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support https://ClinicalTrials.gov/show/NCT01330290 Completed UCB Pharma 2012-08-31
NCT01329926 Molecular Analysis of Human Neural Stem Cells https://ClinicalTrials.gov/show/NCT01329926 Enrolling by invitation NeuroGeneration 2020-12-31
NCT04441697 Sleepiness in Parkinson’s Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation https://ClinicalTrials.gov/show/NCT04441697 Recruiting Central Hospital, Nancy, France 2023-06-30
NCT04434898 The Assessment of the Diagnosis and Prognosis of Patients With Alzheimer Disease or Parkinson Disease With Cognitive Impairment by Using Diffusion MRI https://ClinicalTrials.gov/show/NCT04434898 Active, not recruiting Chang Gung Memorial Hospital 2018-10-01
NCT04436848 LRRK2 G2385R Leucocyte and Urine Biomarker Study https://ClinicalTrials.gov/show/NCT04436848 Recruiting University of Malaya 2021-12-31
NCT04420910 Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04420910 Completed Ankara Yildirim Beyazıt University 2019-08-15
NCT04386863 Taxonomy of Neurorehabilitation Treatments and Outcome Measures: a Multicentre Italian Study https://ClinicalTrials.gov/show/NCT04386863 Recruiting Fondazione Don Carlo Gnocchi Onlus 2020-07-07
NCT04349865 LRRK2 Activity and Markers of Parkinson’s Disease in G2385R Carriers https://ClinicalTrials.gov/show/NCT04349865 Recruiting Xuanwu Hospital, Beijing 2020-06-30
NCT04308135 Differences Between Patients With Vascular Parkinsonism and Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04308135 Recruiting Ain Shams University 2021-09-01
NCT04297800 Gait Characteristics and Cognitive Evolution in Parkinson Disease https://ClinicalTrials.gov/show/NCT04297800 Recruiting Fondazione per la Ricerca Ospedale Maggiore 2023-11-30
NCT04300608 Measures of Mitochondria Dysfunction in PD https://ClinicalTrials.gov/show/NCT04300608 Recruiting University of Washington 2020-07-31
NCT04287465 Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode https://ClinicalTrials.gov/show/NCT04287465 Recruiting Hospital District of Helsinki and Uusimaa 2021-08-01
NCT04273672 Speech, Linguistic and Acoustic Markers in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04273672 Recruiting University of Massachusetts, Worcester 2022-02-28
NCT04270604 Biological Sample Collection for Research and Biobanking https://ClinicalTrials.gov/show/NCT04270604 Recruiting The New York Stem Cell Foundation 2030-01-31
NCT04268030 High Order Spectral Analysis of Local Field Potential Data on a Subgroup of Parkinson’s Disease Patients Who Are Carriers of Mutations in the Glucocerebrosidase (GBA) Gene Undergoing DBS Electrode Placement https://ClinicalTrials.gov/show/NCT04268030 Enrolling by invitation Rush University Medical Center 2020-06-30
NCT04264273 Diagnosis of Parkinson´s Disease by Means of Submandibular Gland Needle Biopsy https://ClinicalTrials.gov/show/NCT04264273 Recruiting Saarland University 2021-12-31
NCT04249245 Role of Nasal Dysbiosis in Parkinson Disease https://ClinicalTrials.gov/show/NCT04249245 Recruiting Institut Pasteur 2022-02-28
NCT04239079 Autoimmune Features of Neurodegenerative Disorders https://ClinicalTrials.gov/show/NCT04239079 Recruiting Columbia University 2022-05-31
NCT04231487 Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders https://ClinicalTrials.gov/show/NCT04231487 Recruiting Rutgers, The State University of New Jersey 2021-12-31
NCT04228172 Genotypic Influences on Network Progression in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04228172 Recruiting Northwell Health 2023-01-01
NCT03377569 Subcortical Oscillations in Human Sleep Dysregulation https://ClinicalTrials.gov/show/NCT03377569 Recruiting University of Colorado, Denver 2020-12-31
NCT04180865 The Dutch Parkinson and Cognition Study https://ClinicalTrials.gov/show/NCT04180865 Recruiting University Medical Center Groningen 2023-10-01
NCT04148326 A Pilot Study to Explore the Role of Gut Flora in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04148326 Recruiting ProgenaBiome 2023-03-31
NCT04142528 Patient-Centered PD Ambulatory Monitoring System https://ClinicalTrials.gov/show/NCT04142528 Enrolling by invitation Great Lakes NeuroTechnologies Inc. 2020-06-30
NCT04139551 Oxford Study of Quantification in Parkinsonism https://ClinicalTrials.gov/show/NCT04139551 Recruiting University of Oxford 2020-03-31
NCT04125485 The Optimisation of Parkinson’s Project https://ClinicalTrials.gov/show/NCT04125485 Recruiting University of Southampton 2020-08-30
NCT04121793 Objective Quality of Life Detection Validation https://ClinicalTrials.gov/show/NCT04121793 Recruiting Great Lakes NeuroTechnologies Inc. 2020-06-30
NCT04114994 Longitudinal Cognitive Assessment by BoCA https://ClinicalTrials.gov/show/NCT04114994 Recruiting Alzheimer’s Light LLC 2029-10-01
NCT04104373 The Ontario Neurodegenerative Disease Research Initiative https://ClinicalTrials.gov/show/NCT04104373 Completed Ontario Neurodegeneration Disease Research Initiative 2018-03-31
NCT04101513 The Natural History of Parkinson’s Disease-associated Spinal Disorders https://ClinicalTrials.gov/show/NCT04101513 Recruiting Ohio State University 2021-02-14
NCT04101968 The GBA Multimodal Study in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04101968 Recruiting Pacific Parkinson’s Research Centre 2021-04-30
NCT04093908 Prediction of STN DBS Motor Response in PD https://ClinicalTrials.gov/show/NCT04093908 Enrolling by invitation Maastricht University Medical Center 2019-12-17
NCT04064294 Preventing Levodopa Induced Dyskinesia in Parkinson’s Disease With HMG-CoA Reductase Inhibitors https://ClinicalTrials.gov/show/NCT04064294 Active, not recruiting VA Office of Research and Development 2022-12-31
NCT04051125 Evaluation of Anticholinergic Load https://ClinicalTrials.gov/show/NCT04051125 Completed University Hospital, Montpellier 2019-11-01
NCT04042675 The Effects of Respiratory Muscle Strength in Parkinson Disease https://ClinicalTrials.gov/show/NCT04042675 Recruiting Istanbul Medeniyet University 2020-02-20
NCT04023201 Nocturnal Symptoms and Quality of Life in Patients With Parkinson’s Disease in Shanghai https://ClinicalTrials.gov/show/NCT04023201 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2019-12-31
NCT04020198 Pilot Biomarker Study Assessing Alpha-synuclein Aggregates in Parkinson’s Disease, Multiple System Atrophy, and Rapid Eye Movement Sleep Behavior Disorder https://ClinicalTrials.gov/show/NCT04020198 Recruiting Stony Brook University 2021-02-28
NCT03994328 An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD https://ClinicalTrials.gov/show/NCT03994328 Recruiting Zambon SpA 2021-06-30
NCT03992625 Clinical Outcomes for Deep Brain Stimulation https://ClinicalTrials.gov/show/NCT03992625 Recruiting Washington University School of Medicine 2030-01-01
NCT03982953 Predicting Cognition After DBS for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03982953 Recruiting Charite University, Berlin, Germany 2022-02-10
NCT03981913 Cognitive Control in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03981913 Recruiting Rennes University Hospital 2020-12-06
NCT03960242 Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease. https://ClinicalTrials.gov/show/NCT03960242 Recruiting BrainEver 2022-10-30
NCT03958175 The Alouette Test in Parkinson Disease https://ClinicalTrials.gov/show/NCT03958175 Completed Hospices Civils de Lyon 2016-04-01
NCT03945968 The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. https://ClinicalTrials.gov/show/NCT03945968 Recruiting Russian Federation of Anesthesiologists and Reanimatologists 2020-12-30
NCT03944785 Clinical Outcome Assessment of Parkinson’s Disease Patients Treated With XADAGO (Safinamide) https://ClinicalTrials.gov/show/NCT03944785 Completed US WorldMeds LLC 2019-12-23
NCT03937284 Lipoprotein Metabolism and Bacterial Lipopolysaccharide in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03937284 Completed University of Milan 2017-10-20
NCT03938974 Social Self-Management of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03938974 Completed Tufts University 2019-03-28
NCT03921697 Improving Walking Ability in Parkinson Disease https://ClinicalTrials.gov/show/NCT03921697 Recruiting Fondazione Don Carlo Gnocchi Onlus 2020-05-31
NCT03905954 The Impact of a Diagnosis of Parkinson’s on Work https://ClinicalTrials.gov/show/NCT03905954 Completed Oxford Brookes University 2019-11-04
NCT03887663 Chinese PD Registry https://ClinicalTrials.gov/show/NCT03887663 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03886753 Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products https://ClinicalTrials.gov/show/NCT03886753 Active, not recruiting Children’s Hospital of Philadelphia 2020-12-31
NCT03884231 MRI Study of Infinity DBS System https://ClinicalTrials.gov/show/NCT03884231 Recruiting Abbott Medical Devices 2021-04-30
NCT03866603 Rostock International Parkinson’s Disease Study (ROPAD) https://ClinicalTrials.gov/show/NCT03866603 Recruiting Centogene AG Rostock 2021-12-31
NCT03866044 Unravelling the Alteration of Brain Structure and Function in Parkinson´s Disease With Ultra-high Field MRI https://ClinicalTrials.gov/show/NCT03866044 Recruiting Danish Research Centre for Magnetic Resonance 2020-08-01
NCT03848455 Multi-chip Meta-analysis of Parkinson’s Disease for Clinical Validation of Small Samples of Key Genes in Disease https://ClinicalTrials.gov/show/NCT03848455 Completed Zhujiang Hospital 2019-09-20
NCT03845725 Falls and Balance of Patients With Parkinson’s Disease With Urinary Disturbance https://ClinicalTrials.gov/show/NCT03845725 Completed T.C. ORDU ÜNİVERSİTESİ 2019-06-30
NCT03837067 Use and Misuse of Domperidone in Parkinson’s Disease in France - Dump Investigation https://ClinicalTrials.gov/show/NCT03837067 Recruiting Assistance Publique - Hôpitaux de Paris 2019-06-30
NCT03827746 The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson’s Disease Patients https://ClinicalTrials.gov/show/NCT03827746 Completed Istanbul Kültür University 2019-04-01
NCT03811496 Biomarker Analysis for GBA Associated Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03811496 Recruiting Lysosomal and Rare Disorders Research and Treatment Center, Inc. 2020-02-29
NCT03793491 Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03793491 Active, not recruiting University Hospital, Toulouse 2020-12-18
NCT03792204 the Prevalence of “Wearing-off” in Patients With Parkinson’s Disease in Shanghai https://ClinicalTrials.gov/show/NCT03792204 Completed Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2018-08-31
NCT03782753 Molecular Pathology and Neuronal Networks in LRRK2 Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03782753 Recruiting King’s College London 2021-01-14
NCT03779880 Examining Parkinson’s Disease-Related Retirement: Results of Turkey https://ClinicalTrials.gov/show/NCT03779880 Completed Istanbul Kültür University 2018-12-31
NCT03775447 Fox BioNet Project: ECV-003 https://ClinicalTrials.gov/show/NCT03775447 Completed Michael J. Fox Foundation for Parkinson’s Research 2019-12-18
NCT03763955 Effectiveness of MIRT on Hand and Finger Dexterity in PD Patients https://ClinicalTrials.gov/show/NCT03763955 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2018-08-01
NCT03743467 Study on the Visual Condition in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03743467 Recruiting Neuromed IRCCS 2018-11-05
NCT03727139 Rasagiline Tablets Special Drug Use-Results Survey “Survey on Long-term Safety” https://ClinicalTrials.gov/show/NCT03727139 Recruiting Takeda 2021-10-31
NCT03717376 Movement Disorders and Early Maladaptive Schemas https://ClinicalTrials.gov/show/NCT03717376 Recruiting Assistance Publique - Hôpitaux de Paris 2020-02-12
NCT03705520 Targeting Diet-Microbiome Interactions in the Pathogenesis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03705520 Recruiting Rush University Medical Center 2021-05-31
NCT03687203 Cognitive-driven ADL Impairment as a Predictor for PDD https://ClinicalTrials.gov/show/NCT03687203 Recruiting University Hospital Tuebingen 2020-09-01
NCT03685357 Correlation Between Idiopathic Parkinson’s Disease and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03685357 Recruiting Ain Shams University 2019-06-30
NCT03681015 Wearable Assessments in the Clinic and Home in PD https://ClinicalTrials.gov/show/NCT03681015 Recruiting University of Rochester 2021-03-01
NCT03664609 Deep Brain Stimulation (DBS) Retrospective Outcomes Study https://ClinicalTrials.gov/show/NCT03664609 Recruiting Boston Scientific Corporation 2028-06-29
NCT03662009 Multi-limb Dual-task Control in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03662009 Recruiting A.T. Still University of Health Sciences 2020-06-01
NCT03655171 A Pilot Study to Evaluate the Severity of Motor Dysfunction in Parkinson’s Disease Based on AI Video Analysis https://ClinicalTrials.gov/show/NCT03655171 Completed Huashan Hospital 2018-10-20
NCT03647137 Amyloidopathy, Choinopathy, Dopamine Responsiveness and Freezing of Gait in PD https://ClinicalTrials.gov/show/NCT03647137 Recruiting VA Office of Research and Development 2021-06-07
NCT03645538 Analysis of Cortical Biomarkers for PD https://ClinicalTrials.gov/show/NCT03645538 Recruiting Universidade Federal de Pernambuco 2019-01-30
NCT03648671 Pain in Parkinson’s Disease With Motor Fluctuations. https://ClinicalTrials.gov/show/NCT03648671 Recruiting Universita di Verona 2019-03-28
NCT03633513 Parkinson’s Disease Inflammatory Biomarker Profiling https://ClinicalTrials.gov/show/NCT03633513 Recruiting Longevity Biotech 2019-12-31
NCT03608228 Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks https://ClinicalTrials.gov/show/NCT03608228 Recruiting University of California, Los Angeles 2020-09-01
NCT03602924 Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion https://ClinicalTrials.gov/show/NCT03602924 Recruiting Hospital Universitari Vall d’Hebron Research Institute 2018-07-18
NCT03589872 The Fine Motor Dexterity Under Dual Task in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03589872 Active, not recruiting T.C. ORDU ÜNİVERSİTESİ 2018-12-15
NCT03580486 Investigation of the Psychometric Properties of the Squares Test in Measuring Hand Function in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03580486 Completed Gazi University 2015-08-17
NCT03582163 Longitudinal Outcomes of DBS in PD https://ClinicalTrials.gov/show/NCT03582163 Enrolling by invitation Vanderbilt University Medical Center 2020-12-31
NCT03573232 Prevalence of Abnormal Postures in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03573232 Recruiting Universita di Verona 2018-10-07
NCT03554551 Imaging the Vesicular Acetylcholine Transporter Using 18F-FEOBV PET in Parkinsons Disease https://ClinicalTrials.gov/show/NCT03554551 Recruiting Aarhus University Hospital 2021-06-30
NCT03545425 Fox BioNet Project: LRRK2-002 https://ClinicalTrials.gov/show/NCT03545425 Completed Michael J. Fox Foundation for Parkinson’s Research 2020-04-30
NCT03536104 Identification of Risk Factors Parkinson’s Disease by Convergence Strategy https://ClinicalTrials.gov/show/NCT03536104 Recruiting University Hospital, Lille 2024-03-31
NCT03538262 Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials https://ClinicalTrials.gov/show/NCT03538262 Enrolling by invitation Massachusetts General Hospital 2022-04-30
NCT03531086 Idiopathic Parkinson’s Progression and Dopamine Transporter SPECT https://ClinicalTrials.gov/show/NCT03531086 Active, not recruiting University of Kentucky 2020-09-30
NCT03528460 Predictive Factors of Short/Long-term Outcome and Complications of Bilateral DBS in PD https://ClinicalTrials.gov/show/NCT03528460 Completed University Hospital, Grenoble 2018-05-04
NCT03523065 Chinese PD-GBA Registry https://ClinicalTrials.gov/show/NCT03523065 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03523104 Chinese PD-LRRK2 Registry https://ClinicalTrials.gov/show/NCT03523104 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03523052 Chinese PD-SNCA Registry https://ClinicalTrials.gov/show/NCT03523052 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03517059 Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson’s Disease https://ClinicalTrials.gov/show/NCT03517059 Recruiting University Hospital, Lille 2020-05-31
NCT03508986 Chinese FPD Registry https://ClinicalTrials.gov/show/NCT03508986 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03508960 Chinese EOPD Registry https://ClinicalTrials.gov/show/NCT03508960 Recruiting Xiangya Hospital of Central South University 2027-02-01
NCT03433950 Clinical Characteristics of Parkinson’s Disease Subjects With Severe Hypertension During Motor OFFs. https://ClinicalTrials.gov/show/NCT03433950 Recruiting Oregon Health and Science University 2019-12-31
NCT03432338 Distribution of Non-Motor Symptoms in Idiopathic Parkinson’s Disease and Secondary Parkinsonism https://ClinicalTrials.gov/show/NCT03432338 Completed Region Jönköping County 2016-12-31
NCT03421899 A Study Into the Underlying Biochemical Pathways Involved in Parkinson’s Disease, Such as Mitochondrial (Cellular “Powerhouse”) Dysfunction https://ClinicalTrials.gov/show/NCT03421899 Enrolling by invitation University College, London 2020-08-31
NCT03413787 The Türkish Version of the Freezing of Gait Questionnaire https://ClinicalTrials.gov/show/NCT03413787 Completed T.C. ORDU ÜNİVERSİTESİ 2018-02-12
NCT03415984 Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson’s Patients and Assesment of the Role of L-DOPA https://ClinicalTrials.gov/show/NCT03415984 Completed Fondation Ophtalmologique Adolphe de Rothschild 2019-01-15
NCT01251094 Dementia Registry for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01251094 Completed China Medical University Hospital 2011-11-30
NCT01246336 Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson’s Disease From Exhaled Breath https://ClinicalTrials.gov/show/NCT01246336 Completed Rambam Health Care Campus 2012-01-31
NCT01237210 7T MRS in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01237210 Completed University of Minnesota 2019-02-28
NCT01210534 Physiological Brain Atlas Development https://ClinicalTrials.gov/show/NCT01210534 Active, not recruiting Ohio State University 2020-08-31
NCT01174758 Development of an Instrumented System to Measure Mobility in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01174758 Completed Oregon Health and Science University 2014-10-31
NCT01167608 Barriers to Mental Healthcare Utilization in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01167608 Completed Rutgers, The State University of New Jersey 2013-03-31
NCT01163344 Dance Exercise as Novel Complementary Therapy for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01163344 Completed Beth Israel Deaconess Medical Center 2015-12-31
NCT01159691 Change in Gastrointestinal Complaints After Switch From Oral Parkinson’s Disease Treatment to Neupro® Transdermal Patch https://ClinicalTrials.gov/show/NCT01159691 Completed UCB Pharma 2012-03-31
NCT01155492 Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01155492 Completed Rush University Medical Center 2012-12-31
NCT01149811 A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01149811 Completed Bausch Health Americas, Inc. 2010-11-30
NCT01142739 Phosphorylation of ERK1/2 in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01142739 Completed University Hospital, Bordeaux 2012-07-31
NCT01143454 Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System https://ClinicalTrials.gov/show/NCT01143454 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01140841 A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson’s Disease Who Are Receiving Levodopa https://ClinicalTrials.gov/show/NCT01140841 Completed Bausch Health Americas, Inc. 2010-11-30
NCT01113684 Study of Subthalamic Brain Stimulation in Parkinson Disease (PD) https://ClinicalTrials.gov/show/NCT01113684 Completed University of Alabama at Birmingham 2014-11-30
NCT01113242 Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01113242 Completed University Hospital, Strasbourg, France 2012-08-31
NCT01106976 Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease https://ClinicalTrials.gov/show/NCT01106976 Completed VA Office of Research and Development 2014-09-30
NCT01102582 An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson’s Disease Dementia https://ClinicalTrials.gov/show/NCT01102582 Completed The Catholic University of Korea 2011-02-28
NCT01100073 Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life https://ClinicalTrials.gov/show/NCT01100073 Completed Boehringer Ingelheim 2009-08-31
NCT01097421 Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease https://ClinicalTrials.gov/show/NCT01097421 Completed Boehringer Ingelheim 2011-09-30
NCT01071590 The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of Gait https://ClinicalTrials.gov/show/NCT01071590 Completed National Institutes of Health Clinical Center (CC) NA
NCT01061567 Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson’s Disease in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01061567 Completed Boehringer Ingelheim 2013-06-30
NCT01052350 PET Imaging in Parkinson Disease Dementia https://ClinicalTrials.gov/show/NCT01052350 Active, not recruiting Washington University School of Medicine 2030-07-31
NCT01052948 The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events https://ClinicalTrials.gov/show/NCT01052948 Completed Pfizer 2009-12-31
NCT01038310 Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease https://ClinicalTrials.gov/show/NCT01038310 Completed Saarland University 2010-07-31
NCT01032486 Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01032486 Completed Teva Pharmaceutical Industries 2011-06-30
NCT01022073 Follow Up Study for Treatment of Parkinson’s Disease With Deep Brain Stimulation https://ClinicalTrials.gov/show/NCT01022073 Completed VA Office of Research and Development 2015-03-31
NCT00999388 Shanghai Parkinson’s Study https://ClinicalTrials.gov/show/NCT00999388 Completed National Institutes of Health Clinical Center (CC) NA
NCT01003535 Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods https://ClinicalTrials.gov/show/NCT01003535 Completed Saarland University 2012-04-30
NCT00936676 ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson’s Disease Subjects https://ClinicalTrials.gov/show/NCT00936676 Completed Teva Pharmaceutical Industries 2013-03-31
NCT00932581 Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties https://ClinicalTrials.gov/show/NCT00932581 Completed Teva Pharmaceutical Industries 2009-11-30
NCT00918112 Development of a Face Valid Executive Functioning Task https://ClinicalTrials.gov/show/NCT00918112 Completed Washington University School of Medicine 2009-09-30
NCT00917722 Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control https://ClinicalTrials.gov/show/NCT00917722 Completed Washington University School of Medicine 2009-03-31
NCT00917280 Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson’s Disease (PD) Without Dementia https://ClinicalTrials.gov/show/NCT00917280 Completed Washington University School of Medicine 2014-07-31
NCT00913640 Prospective Memory in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00913640 Completed Washington University School of Medicine NA
NCT00912977 Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia https://ClinicalTrials.gov/show/NCT00912977 Completed Oregon Health and Science University 2010-06-30
NCT00862537 Evaluation of Long-term Effect of Resonator Therapy on Parkinson’s Disease (PD) https://ClinicalTrials.gov/show/NCT00862537 Completed pico-tesla Magnetic Therapies, LLC 2011-04-30
NCT00847431 Mapping Mood in the Subthalamic Nucleus in Parkinson’s Disease (PD) https://ClinicalTrials.gov/show/NCT00847431 Completed Washington University School of Medicine 2014-12-31
NCT00839514 Trichloroethylene (TCE) Exposure in an Industrial Population https://ClinicalTrials.gov/show/NCT00839514 Completed University of Kentucky 2009-08-31
NCT00841464 Study on the Effect of External Magnetic Stimulation on Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00841464 Completed Parkinson’s Disease Research, Education, and Clinical Center, Philadelphia NA
NCT04214509 LIPAD - LRRK2 International Parkinson’s Disease Study https://ClinicalTrials.gov/show/NCT04214509 Recruiting University of Luebeck 2021-12-31
NCT04110106 Correlation Between Quality of Life and Severity of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04110106 Completed R.O.M.A. - Rehabilitation & Outcome Measures Assessment 2019-03-25
NCT03638479 Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders https://ClinicalTrials.gov/show/NCT03638479 Recruiting Westfälische Wilhelms-Universität Münster 2020-10-31
NCT02194816 Complementary & Alternative Medicine in Parkinson’s Disease (CAM Care in PD) https://ClinicalTrials.gov/show/NCT02194816 Recruiting Bastyr University 2030-12-31
NCT04353947 Induction and Recognition of Emotions https://ClinicalTrials.gov/show/NCT04353947 Recruiting University of Valencia 2020-10-30
NCT04196647 Guideline for Hometitration With Duodopa for Parkinson Patients https://ClinicalTrials.gov/show/NCT04196647 Recruiting Rigshospitalet, Denmark 2020-12-31
NCT01747655 A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson’s Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study https://ClinicalTrials.gov/show/NCT01747655 Completed AbbVie 2015-07-31
NCT00775853 Biomarkers of Risk of Parkinson Disease https://ClinicalTrials.gov/show/NCT00775853 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT00802178 First Presentation of Parkinson Disease Patients to Neurologist https://ClinicalTrials.gov/show/NCT00802178 Completed Boehringer Ingelheim 2007-09-30
NCT00367900 Parkinson’s Genes and Environment Study https://ClinicalTrials.gov/show/NCT00367900 Completed National Institutes of Health Clinical Center (CC) NA
NCT00302146 Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations https://ClinicalTrials.gov/show/NCT00302146 Completed National Institutes of Health Clinical Center (CC) NA
NCT03733496 Observational, Long-term, Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Studies https://ClinicalTrials.gov/show/NCT03733496 Enrolling by invitation Neurocrine Biosciences 2026-08-31
NCT03645226 Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03645226 Recruiting Chinese University of Hong Kong 2020-08-31
NCT02422992 Haptoglobin and Iron in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02422992 Completed Bastyr University 2016-06-30
NCT04071847 Abbott DBS Registry of Outcomes for Indications Over Time https://ClinicalTrials.gov/show/NCT04071847 Recruiting Abbott Medical Devices 2029-09-30
NCT02349789 The Role of Cerebellar Hyperactivity in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02349789 Completed Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 2016-10-04
NCT02028858 Cannabis and Parkinson’s Disease Tremor: A Natural History Study https://ClinicalTrials.gov/show/NCT02028858 Completed Bastyr University 2015-10-31
NCT04453995 A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04453995 Active, not recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2021-12-31
NCT00792532 Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes https://ClinicalTrials.gov/show/NCT00792532 Completed University of California, San Francisco 2019-03-31
NCT00766948 The Parkinson’s Disease NeuroGenebank at Scripps Clinic Registry https://ClinicalTrials.gov/show/NCT00766948 Active, not recruiting Scripps Translational Science Institute 2030-08-31
NCT00752388 Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00752388 Completed Boehringer Ingelheim 2008-11-30
NCT00737217 Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00737217 Completed University of Michigan 2009-04-30
NCT00727727 SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson’s Disease (PIR-002/K) https://ClinicalTrials.gov/show/NCT00727727 Completed Desitin Arzneimittel GmbH 2008-12-31
NCT00736671 Striatal and Extra-striatal Mechanisms of Falling in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00736671 Completed University of Michigan 2010-04-30
NCT00725478 SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00725478 Completed Desitin Arzneimittel GmbH 2008-06-30
NCT00677885 P-glycoprotein Function in Brain Diseases https://ClinicalTrials.gov/show/NCT00677885 Completed National Institutes of Health Clinical Center (CC) NA
NCT00668551 Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population https://ClinicalTrials.gov/show/NCT00668551 Completed University of Rochester 2008-11-30
NCT00654563 Memory Disorders Registry https://ClinicalTrials.gov/show/NCT00654563 Completed Cedars-Sinai Medical Center 2012-03-31
NCT00651183 Non-motor Symptoms (Depressive Symptoms) of Parkinson’s Disease and Their Course Under Pramipexole Treatment https://ClinicalTrials.gov/show/NCT00651183 Completed Boehringer Ingelheim 2008-04-30
NCT00639275 Deep Brain Stimulation and Digestive Symptomatology https://ClinicalTrials.gov/show/NCT00639275 Completed University Hospital, Rouen 2012-06-30
NCT00617019 Impulse Control Disorders in Parkinson’s Patients Treated With Pramipexole and Other Agents (DOMINION Study) https://ClinicalTrials.gov/show/NCT00617019 Completed Boehringer Ingelheim 2008-01-31
NCT00615914 Special Survey on Parkinson’s Disease Patients Treated Long-term Use of Pramipexole https://ClinicalTrials.gov/show/NCT00615914 Completed Boehringer Ingelheim 2009-03-31
NCT00614575 Survey on PD Patients With Depressive Symptoms https://ClinicalTrials.gov/show/NCT00614575 Completed Boehringer Ingelheim 2009-08-31
NCT00613301 Special Survey on Parkinson’s Disease (PD) Patients Without Concomitant Use of L-Dopa https://ClinicalTrials.gov/show/NCT00613301 Completed Boehringer Ingelheim 2009-09-30
NCT00613756 Special Survey on PD Patients With Renal Dysfunction https://ClinicalTrials.gov/show/NCT00613756 Completed Boehringer Ingelheim 2008-09-30
NCT00599339 Transdermal Rotigotine User Surveillance Study https://ClinicalTrials.gov/show/NCT00599339 Completed UCB Pharma 2014-04-30
NCT00575081 Physiological Brain Atlas Development https://ClinicalTrials.gov/show/NCT00575081 Recruiting Vanderbilt University Medical Center 2023-07-31
NCT00558766 Motor Cortex Reward Signaling in Parkinson Disease https://ClinicalTrials.gov/show/NCT00558766 Completed National Institutes of Health Clinical Center (CC) NA
NCT00539214 Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00539214 Completed Boehringer Ingelheim 2007-12-31
NCT00528086 A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00528086 Completed University of Rochester 2009-08-31
NCT00518258 Neuroimaging Studies of Depression in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00518258 Completed University of Kentucky 2011-12-31
NCT01135407 Visual Selective Attention in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT01135407 Completed University Hospital, Grenoble 2010-07-31
NCT00476372 Cognitive Impairment in Parkinson’s Disease Categorised in Accordance to Motor Symptoms https://ClinicalTrials.gov/show/NCT00476372 Completed University of Aarhus 2011-12-31
NCT00467597 Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1) https://ClinicalTrials.gov/show/NCT00467597 Completed VA Office of Research and Development 2008-08-31
NCT00466739 European Compliance Study in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00466739 Completed South Glasgow University Hospitals NHS Trust NA
NCT00465790 Research of Biomarkers in Parkinson Disease https://ClinicalTrials.gov/show/NCT00465790 Completed Institut National de la Santé Et de la Recherche Médicale, France 2012-06-30
NCT00460954 A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects https://ClinicalTrials.gov/show/NCT00460954 Completed Bristol-Myers Squibb NA
NCT00443768 Medication Review in Patients on Anti-parkinson Therapy https://ClinicalTrials.gov/show/NCT00443768 Completed South Glasgow University Hospitals NHS Trust 2008-08-31
NCT00431366 Sequence Effect in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00431366 Completed National Institutes of Health Clinical Center (CC) NA
NCT00396942 Motor Skill Learning in People With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00396942 Completed National Institutes of Health Clinical Center (CC) NA
NCT00368199 Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes https://ClinicalTrials.gov/show/NCT00368199 Completed Maastricht University Medical Center 2008-09-18
NCT00360633 Psychiatric and Cognitive Manifestations of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00360633 Completed NYU Langone Health 2019-03-28
NCT00361465 DYSCAR: Characterization of Dystonia https://ClinicalTrials.gov/show/NCT00361465 Completed University Hospital, Grenoble NA
NCT00358189 Effects of Deep Brain Stimulation for the Treatment of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00358189 Completed VA Office of Research and Development NA
NCT00349310 Profile of Depressive Symptoms in Parkinsons Disease https://ClinicalTrials.gov/show/NCT00349310 Completed Boehringer Ingelheim 2006-10-31
NCT00311532 Observational Study of Pergolide Mesylate and Cardiac Valvulopathy https://ClinicalTrials.gov/show/NCT00311532 Completed Eli Lilly and Company NA
NCT00291265 Measures of Motor Impairment in Early Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00291265 Completed National Institutes of Health Clinical Center (CC) NA
NCT00245700 Adherence of Stalevo, Entacapone and Levodopa https://ClinicalTrials.gov/show/NCT00245700 Completed South Glasgow University Hospitals NHS Trust NA
NCT00234364 Pergolide Treatment and Valvular Heart Disease https://ClinicalTrials.gov/show/NCT00234364 Completed Ã…rhus Amt NA
NCT00203008 A Survey Study to See if Patients Diagnosed With Parkinson’s Disease Have Higher Incidence of Melanoma https://ClinicalTrials.gov/show/NCT00203008 Completed Teva Pharmaceutical Industries NA
NCT00202657 Observational Study of Heart Valve Disease in Patients With Parkinson’s Disease Treated With Pergolide https://ClinicalTrials.gov/show/NCT00202657 Completed Société Française de Cardiologie NA
NCT00148369 A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson’s Disease Previously Treated With Intraputaminal Infusion of Liatermin https://ClinicalTrials.gov/show/NCT00148369 Completed Amgen 2006-11-30
NCT00117195 A Study of Neurophysiologic Changes in Individuals With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00117195 Completed Institute for Neurodegenerative Disorders 2011-01-31
NCT00105131 Genetic Characterization of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00105131 Completed National Institutes of Health Clinical Center (CC) NA
NCT00100438 Incidence of Parkinson’s Disease Among Veterans https://ClinicalTrials.gov/show/NCT00100438 Completed VA Office of Research and Development NA
NCT00096876 A Study of the Sense of Smell in Relatives of Parkinson’s Disease Patients https://ClinicalTrials.gov/show/NCT00096876 Completed Institute for Neurodegenerative Disorders 2008-06-30
NCT00088335 Biological Markers in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00088335 Completed National Institutes of Health Clinical Center (CC) NA
NCT00094601 Relationship of Dopamine to Cognitive Function in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00094601 Completed National Institutes of Health Clinical Center (CC) NA
NCT00086073 Parkinson’s Research: The Organized Genetics Initiative https://ClinicalTrials.gov/show/NCT00086073 Completed Indiana University NA
NCT00063661 Studying Automatic Movements in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00063661 Completed National Institutes of Health Clinical Center (CC) NA
NCT00076505 Cell Studies of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00076505 Completed National Institutes of Health Clinical Center (CC) NA
NCT00058721 Single Photon Emission Computed Tomography to Study Receptors in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00058721 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001665 Transcranial Magnetic Stimulation for the Treatment of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00001665 Completed National Institutes of Health Clinical Center (CC) NA
NCT00044590 Parkinson’s Diseases Susceptibility Genes and Pesticides https://ClinicalTrials.gov/show/NCT00044590 Completed National Institute of Environmental Health Sciences (NIEHS) 2016-11-30
NCT00001928 Intravenous Levodopa for the Diagnosis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00001928 Completed National Institutes of Health Clinical Center (CC) NA
NCT00042692 Catechol Thioethers in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00042692 Completed National Institute of Environmental Health Sciences (NIEHS) NA
NCT00042120 Farming and Movement Evaluation Study (FAME) https://ClinicalTrials.gov/show/NCT00042120 Completed National Institute of Environmental Health Sciences (NIEHS) 2011-07-31
NCT00040196 How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance https://ClinicalTrials.gov/show/NCT00040196 Completed National Institutes of Health Clinical Center (CC) 2009-07-09
NCT00042107 Molecular Epidemiology of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00042107 Completed National Institute of Environmental Health Sciences (NIEHS) NA
NCT00032812 The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00032812 Completed National Institutes of Health Clinical Center (CC) NA
NCT00026598 Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00026598 Completed National Institutes of Health Clinical Center (CC) NA
NCT00023062 Transcranial Magnetic Stimulation in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00023062 Completed National Institutes of Health Clinical Center (CC) NA
NCT00018577 The Association of Neurotoxin Exposure With Parkinson’s Disease and Parkinsonism in World War II Veterans and Other Men https://ClinicalTrials.gov/show/NCT00018577 Completed VA Office of Research and Development NA
NCT00179101 Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson’s Patients https://ClinicalTrials.gov/show/NCT00179101 Completed Vanderbilt University NA
NCT00001643 Gene Analysis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00001643 Completed National Institutes of Health Clinical Center (CC) 2009-08-31
NCT00001776 Effects of Brain Stimulation on Learning and Reasoning https://ClinicalTrials.gov/show/NCT00001776 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001549 Diagnosis and Natural History Study of Patients With Neurological Conditions https://ClinicalTrials.gov/show/NCT00001549 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001640 Genetic Analysis of Parkinson’s Disease https://ClinicalTrials.gov/show/NCT00001640 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001258 Studies of Frontal Lobe Brain Functioning in Schizophrenia https://ClinicalTrials.gov/show/NCT00001258 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03406754 Multi-disciplinary Rehabilitation Program for Advanced Parkinson’s Patients in the Community https://ClinicalTrials.gov/show/NCT03406754 Active, not recruiting Tel-Aviv Sourasky Medical Center 2021-12-31
NCT03130595 West Sweden Parkinson Objective Measurement Registry Study https://ClinicalTrials.gov/show/NCT03130595 Active, not recruiting Sahlgrenska University Hospital, Sweden 2020-09-30
NCT03100474 Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders: https://ClinicalTrials.gov/show/NCT03100474 Active, not recruiting InSightec 2021-01-31
NCT03021031 Circuit-Based Deep Brain Stimulation for Parkinson’s Disease; Udall Clinical Core https://ClinicalTrials.gov/show/NCT03021031 Enrolling by invitation University of Minnesota 2022-01-31
NCT02652104 Deep Brain Stimulation in HUCH Region Between 2006 and 2014 https://ClinicalTrials.gov/show/NCT02652104 Completed Hospital District of Helsinki and Uusimaa 2014-12-31
NCT02474329 Real-PD Trial: Development of Clinical Prognostic Models for Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02474329 Completed Radboud University 2016-11-30
NCT02460796 Hippotherapy and Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02460796 Completed University of Brasilia 2013-09-30
NCT02071134 Registry of Deep Brain Stimulation With the VERCISEâ„¢ System: Vercise DBS Registry https://ClinicalTrials.gov/show/NCT02071134 Recruiting Boston Scientific Corporation 2024-12-31
NCT02060695 Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations https://ClinicalTrials.gov/show/NCT02060695 Recruiting Seoul National University Hospital 2030-06-30
NCT01878409 Study of Sexuality in Parkinson Disease https://ClinicalTrials.gov/show/NCT01878409 Completed Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico 2012-11-30
NCT01865877 Motor, Non-motor and Genetic Determinants of Progression in Parkinson’s Disease: A Mexican Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT01865877 Completed El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 2016-08-31
NCT04288804 A Study to Analyze Symptoms Prevalent in Early PD (Dysphonia, Tremor) https://ClinicalTrials.gov/show/NCT04288804 Recruiting Goalspal LLC 2020-12-26
NCT04267341 Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04267341 Active, not recruiting Hacettepe University 2020-03-15
NCT04189887 Single Bout Exercise on Learning in PD https://ClinicalTrials.gov/show/NCT04189887 Recruiting National Taiwan University Hospital 2021-07-31
NCT04189042 Figure-of-Eight Walk Test in Parkinson https://ClinicalTrials.gov/show/NCT04189042 Recruiting Gazi University 2020-02-28
NCT04062279 Predictors of Parkinson’s Disease Progression https://ClinicalTrials.gov/show/NCT04062279 Recruiting Ain Shams University 2022-04-30
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03623672 North American Prodromal Synucleinopathy Consortium https://ClinicalTrials.gov/show/NCT03623672 Recruiting Washington University School of Medicine 2021-07-31
NCT03587168 The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03587168 Completed Gazi University 2018-08-10
NCT03477578 Freezing of Gait and Cognition https://ClinicalTrials.gov/show/NCT03477578 Completed Ospedale Generale Di Zona Moriggia-Pelascini 2018-02-28
NCT02760108 Parkinson’s Families Project https://ClinicalTrials.gov/show/NCT02760108 Recruiting University College, London 2027-01-31